Advanced search

Drug formulations intended for the global market should be tested for stability under tropical climatic conditions

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
RISHA, PG, Chris Vervaet, G VERGOTE, Lucas Van Bortel, and Jean Paul Remon. 2003. “Drug Formulations Intended for the Global Market Should Be Tested for Stability Under Tropical Climatic Conditions.” European Journal of Clinical Pharmacology 59 (2): 135–141.
APA
RISHA, P., Vervaet, C., VERGOTE, G., Van Bortel, L., & Remon, J. P. (2003). Drug formulations intended for the global market should be tested for stability under tropical climatic conditions. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 59(2), 135–141.
Vancouver
1.
RISHA P, Vervaet C, VERGOTE G, Van Bortel L, Remon JP. Drug formulations intended for the global market should be tested for stability under tropical climatic conditions. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2003;59(2):135–41.
MLA
RISHA, PG, Chris Vervaet, G VERGOTE, et al. “Drug Formulations Intended for the Global Market Should Be Tested for Stability Under Tropical Climatic Conditions.” EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 59.2 (2003): 135–141. Print.
@article{211112,
  author       = {RISHA, PG and Vervaet, Chris and VERGOTE, G and Van Bortel, Lucas and Remon, Jean Paul},
  issn         = {0031-6970},
  journal      = {EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY},
  language     = {eng},
  number       = {2},
  pages        = {135--141},
  title        = {Drug formulations intended for the global market should be tested for stability under tropical climatic conditions},
  volume       = {59},
  year         = {2003},
}

Web of Science
Times cited: